Evaluation of combined pharmacological and psychotherapeutic treatment in patients with functional abdominal disorders.
78 patients suffering from various functional abdominal complaints have been trated in a 2 x 2 double-blind design: (a) psychotherapy with Ro 5-3350 (TH/Ro); (b) psychotherapy with placebo (TH/P); (c) Ro 5-3350 without psychotherapy (NIH/Ro); (d) placebo without psychotherapy (NTH/P). Results show that a considerable amount of improvement cannot be ascribed to the two critical factors or the interaction of both, but are due to unspecific influences in the course of treatment. Some of the results concerning the combination of TH and the psychotropic drug pose interesting questions for further research and bare implications for double-blind trials of psychotropic drugs. The results suggest that possibly properties of any psychotropic drug have to be related to a doctor-patient relationship within which the personal problems of the patient are dealt with. In order to evaluate such properties, special methodological precautions have to be taken. These will be briefly discussed.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D010555:Personality Inventory; D010817:Physician-Patient Relations; D011602:Psychophysiologic Disorders / Q000188:drug therapy / Q000628:therapy*; D011614:Psychotherapy, Brief
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines